DALLAS, March 06, 2018 -- Via OTC PR Wire -- Puration, Inc. (USOTC:PURA) wrapped up its launch event at the 30th Annual Arnold Sports Festival in Columbus, Ohio on Sunday reporting an across the board win. Puration’s new Kiwi-Strawberry and Lemmon-Lime flavored EVERx CBD Infused Sports Waters were a hit with athletes and fans. To top off the launch event, EVERx sponsored, main event MMA fighter Cee Jay Hamilton won in a packed arena on Saturday night. Puration signed a 30 pallet order at the event and anticipates several additional larger orders to follow.
|
|||||||||||||||
EVERx Sports Water is built on two patents that together deliver a combination of characteristics that are unprecedented in the beverage industry. In addition to the benefits of its CBD infusions, EVERx Sports Water has an optimal alkaline pH level formulated with antioxidants and electrolytes to deliver the most effective hydration available in the alkaline water market. EVERx was popular at the show with both competitors and fitness enthusiasts of all ages.
Look for information on the EVERx experience at the Arnold coming later this week.
For more information on EVERx, visit http://www.drinkeverx.com.
For more information on Puration, visit http://www.aciconglomerated.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
[email protected]
+1-800-861-1350
Photos accompanying this announcement are available:
http://www.globenewswire.com/NewsRoom/AttachmentNg/370ee293-b928-4c63-a127-ceccfc1b8723
http://www.globenewswire.com/NewsRoom/AttachmentNg/c93314a3-40fb-45e2-8451-6622e2c7b849
http://www.globenewswire.com/NewsRoom/AttachmentNg/5a579f83-e0c8-4edb-96b4-e0555b7a2079


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 



